Search or choose
Find the right test or package.
Identifi - PGx Comprehensive using NGS
The Identifi - PGx Comprehensive using NGS test is an advanced pharmacogenomic screening that uses Next-Generation Sequencing (NGS) to analyze genetic variations affecting the response to over 90 medications across key therapeutic areas. By tailoring treatment...
DiagnosticsLab test
Know more about this test
The Identifi - PGx Comprehensive using NGS test is an advanced pharmacogenomic screening that uses Next-Generation Sequencing (NGS) to analyze genetic variations affecting the response to over 90 medications across key therapeutic areas. By tailoring...
Understanding Identifi - PGx Comprehensive using NGS
The Identifi - PGx Comprehensive using NGS test is an advanced pharmacogenomic screening that uses Next-Generation Sequencing (NGS) to analyze genetic variations affecting the response to over 90 medications across key therapeutic areas. By tailoring treatment plans to an individual’s genetic profile, this test helps reduce trial-and-error in prescribing, minimizes adverse drug reactions, and cuts down on unnecessary treatment costs. It also supports improved treatment adherence by providing actionable insights tha...
What does Identifi - PGx Comprehensive using NGS measure?
The Identifi - PGx Comprehensive using NGS test is an advanced pharmacogenomic screening that uses Next-Generation Sequencing (NGS) to analyze genetic variations affecting the response to over 90 medications across key therapeutic areas. By tailoring treatment plans to an individual’s genetic profile, this test helps reduce trial-and-error in prescribing, minimizes adverse drug reactions, and cuts down on unnecessary treatment costs. It also supports improved treatment adherence by providing actionable insights tha...
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.